Thymodepressin inhibits migration of CD34+ cells from bone marrow in normal and granulocyte CSF-stimulated hemopoiesis.
Semina OV, Semenets TN, Zamulaeva IA, Selivanova EI, Il'ina TP, Malyutina YV, Semin DY, Deigin VI, Saenko AS. · 2007 · Bulletin of experimental biology and medicine
What does this source report?
Mouse CD34-positive cell distribution and adhesion-marker changes suggest altered trafficking. They do not identify a direct molecular receptor or demonstrate human stem-cell expansion.
- Population and setting
- See original report; human, animal and laboratory components must be distinguished.
- Evidence type
- Animal / experimental
- Preparation
- Preparation-specific research; no equivalence inferred
- Source language
- eng
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Full methods, preparation identity and risk of bias require appraisal.
- Related publications may share experiments; source count is not independent-study count.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Semina OV, Semenets TN, Zamulaeva IA, Selivanova EI, Il'ina TP, Malyutina YV, Semin DY, Deigin VI, Saenko AS.. Thymodepressin inhibits migration of CD34+ cells from bone marrow in normal and granulocyte CSF-stimulated hemopoiesis. Bulletin of experimental biology and medicine 2007.
Molekul research summary: https://molekul.io/research/gaps-18856212. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry